Table 3 Univariate analyses showing HRs for patient OS and DFS conferred age, FIGO stage, histologic subtypes, DEF6, p53, p16 and ER expression (N = 180)

0.990

0.900

 ≦50

72

1.00^a

1.00^a

 >50

108

1.003

0.595–1.693

1.034

0.613–1.745

0.023*

0.034*

 I

86

1.00^a

1.00^a

 II

23

1.141

0.518–2.511

1.119

0.509–2.460

 III

64

2.282

1.217–4.279

2.166

1.161–4.040

 IV

7

5.300

1.173–23.950

4.939

1.100–22.172

0.303

0.284

 Serous carcinoma

75

1.00^a

1.00^a

 Mucinous carcinoma

36

0.529

0.247–1.135

0.531

0.247–1.138

 Endometrioid carcinoma

28

0.786

0.342–1.808

0.882

0.382–2.037

 Clear cell carcinoma

41

0.607

0.317–1.162

0.608

0.318–1.163

0.013*

0.009*

 Scores 0 and 1

62

1.00^a

1.00^a

 Scores 2 and 3

118

2.041

1.159–3.594

2.119

1.202–3.737

0.026*

0.031*

 Scores 0 and 1

97

1.00^a

1.00^a

 Scores 2 and 3

80

1.919

1.082–3.402

1.873

1.057–3.318

0.181

0.205

 Scores 1 and 2

81

1.00^a

1.00^a

 Scores 0 and 3

98

1.450

0.841–2.499

1.421

0.825–2.448